
    
      Total 480 hospitalized adult eligible patients will be randomized in 1:1 ratio to receive
      either Mw+SOC or placebo+SOC for first 3 days post-randomization.

      Daily clinical evaluation of patient will be performed till discharge from hospital or till
      ICU admission.

      Study duration for each patient will be approximately up to 28 days, or discharge from
      hospital or transfer to ICU, whichever is earlier.
    
  